Kato J, Futamura M, Kanematsu M, Gaowa S, Mori R, Tanahashi T, Matsuhashi N, Yoshida K. Combination therapy with zoledronic acid and cetuximab effectively suppresses growth of colorectal cancer cells regardless of KRAS status Int J Cancer. 2016 Mar 15; 138(6):1516‐27. Doi: 10.1002/ijc.29881.Epub 2015 Oct 23.
The following errors have been noted.
1. Page1518, line 4 Material and methods, Western blot analysis and antibodies should have read:
Thereafter, the cells were treated with epidermal growth factor (EGF:20 ng/mL)
2. Page1519 Figure legends for Figure 1. Effect of CTX and ZOL on colon cancer cell lines should read:
Figure 1.
(e) The long‐term effects of combination treatment with CTX and ZOL. Representative plates are shown. Numbers of colonies are indicated. Error bars in (b), (c), and (e) indicate standard deviation (SD).→(e) The long‐term effects of combination treatment with CTX and ZOL. Representative plates are shown. (f) Numbers of colonies per dish are indicated. Error bars in (b), (c), and (e) indicate standard deviation (SD).
3. Page 1519 Figure 1, Figure 1C
……×…… ZOL+CTX 1nM → ……▪…… ZOL+CTX 1nM
Dotted line in Figure 1C was wrong. The corrected Figure 1 is shown below.